Quick Insights with Quarles: DEA Proposed Rule for Controlled Substance Prescribing and Telehealth—What Happens Next?
Please join Quarles for a brief webinar highlighting DEA’s Proposed Telehealth Prescribing rule, including the new Special Registration and proposed requirements for telehealth platforms when controlled substances are involved. Gain insight into implications for technology services, healthcare providers, facilities, and patients through this casual, engaging program.
Questions?
Please contact Lauren Klika and Alexa Curto, events@quarles.com.
Continuing Legal Education:
CLE credit is not available for this program.